Goodwin represented Nimbus Therapeutics on the deal Nimbus Therapeutics, a privately held biotechnology company applying deep computational expertise throughout drug discovery and development, has raised $65…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
